<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923543</url>
  </required_header>
  <id_info>
    <org_study_id>(2018/12- 7</org_study_id>
    <nct_id>NCT03923543</nct_id>
  </id_info>
  <brief_title>Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease</brief_title>
  <official_title>Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Firat Ergin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tepecik Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of neutrophil lymphocyte ratio is useful for the detection of infection status in
      newborns after surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of neutrophil lymphocyte ratio is useful for the detection of infection status in
      newborns after surgery and we compare this with other acute phase reactants
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Neutrophil to Lymphocyte Ratio</measure>
    <time_frame>1 day</time_frame>
    <description>We measure this with complete blood count to calculate the percentage of neutrophil count to the number of lymphocytes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neutrophil to Lymphocyte Ratio</measure>
    <time_frame>2 week</time_frame>
    <description>We measure this with complete blood count to calculate the percentage of neutrophil count to the number of lymphocytes</description>
  </primary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Sepsis Newborn</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Neutrophil to lymphosit ratio</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study was conducted in the NICU of Tepecik Training and Research Hospital, İzmir,
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  newborn to be operated with the diagnosis of congenital heart disease

        Exclusion Criteria:

          -  age older than 1 month not to be operated
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2019</study_first_posted>
  <last_update_submitted>April 19, 2019</last_update_submitted>
  <last_update_submitted_qc>April 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tepecik Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Firat Ergin</investigator_full_name>
    <investigator_title>Dr. Fırat ERGİN</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

